Report: HP feared takeover bid from Oracle

Report: HP feared takeover bid from Oracle

The chief change at Hewlett-Packard (HP) has been accelerated by information from the Bloomberg financial news agency of the fear of an offer to buy its competitor Oracle. The Board was concerned that the low stock price makes HP defenseless against possible attack from the Oracle takeover, Bloomberg reported Thursday, citing inaugurated circles. Hewlett-Packard last week, had replaced the former SAP CEO Leo Apotheker by former eBay's Meg Whitman charioteer. Pharmacist since taking office in November, the HP's stock had lost almost half their value.

From the Oracle environment, it said, according to Bloomberg at the same time, the software giant had "considered informally" to establish contact with HP, an offer in the foreseeable future is unlikely. Oracle could be most interested in HP's business with servers, storage and network technology, it said. At the same time the agreement would prohibit the exchange of pharmacist predecessor Mark Hurd to Oracle a takeover offer for the next time.

The mood between the two companies is extremely bad, and not just since the ousted Hurd at HP was a new top job at his friend and Oracle founder Larry Ellison. The two IT heavyweights to compete with each other in ever more areas, for example in server technology. After Ellison was stamped on the HP Board because of the detachment already Hurd as "idiots", is now an Oracle shoots on HP's planned takeover of software specialist Autonomy. The British have also been offered for sale to Oracle, but you've seen the then market price of $ 6 billion to be far too high, HP is now paying more than $ 10 billion. Autonomy CEO Mike Lynch as denied that he had ever offered his company Oracle, said little back diplomatically, "Either Mr. Lynch has a very bad memory or he's lying."

Meanwhile, it was known by a command from HP with the Securities and Exchange Commission that former HP CEO Léo Apotheker from his former company under the termination agreement, a total of 13 million U.S. dollars (9.6 million €) receives. Among them are 7.2 million U.S. dollars, the pharmacist within the next year and a half to be paid, and a - for top managers usually - bonus of 2.4 million U.S. dollars.